Sort
30,917 grants matching “tumor microenvironment”
Project 1 Melnick
$407,046Ari M. Melnick · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2019 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,025Sidi Chen · Yale University · R33 · FY2021 · CA
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers
$407,023Sidi Chen · Yale University · R33 · FY2020 · CA
Imaging of Stromal Cells in the Tumor Microenvironment
$407,005Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2007 · CA
Admin: Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth
$407,005Roger D. Kamm · Massachusetts Institute Of Technology · U54 · FY2022 · CA
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$406,978Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
$406,978Craig B Thompson · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland
$406,935Mark A Labarge · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2014 · AG
BONE MARROW CELL ADHESION MOLECULES
$406,923Oklahoma Medical Research Foundation · R01 · FY2001 · AI
Microarray Core Facility
$406,906Timothy J. Triche · University Of Southern California · P30 · FY2010 · CA
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
$406,852William Nathaniel Brennen · Johns Hopkins University · R01 · FY2023 · CA
Functional Activation of Low Affinity TILs
$406,837Jill E Slansky · University Of Colorado Denver · R01 · FY2022 · CA
OSM-induced IL-6 and ER status in metastatic breast cancer
$406,791Cheryl Lynn Jorcyk · Boise State University · R15 · FY2020 · CA
pH regulation of cell surface receptors
$406,775Daniel Isom · University Of Miami School Of Medicine · R35 · FY2025 · GM
pH regulation of cell surface receptors
$406,775Daniel Isom · University Of Miami School Of Medicine · R35 · FY2024 · GM
pH regulation of cell surface receptors
$406,775Daniel Isom · University Of Miami School Of Medicine · R35 · FY2023 · GM
pH regulation of cell surface receptors
$406,775Daniel Isom · University Of Miami School Of Medicine · R35 · FY2022 · GM
Identifying host factors that block engraftment and progression of transmissible cancer as a model of AML
$406,685Michael Jeffrey Metzger · Pacific Northwest Research Institute · R01 · FY2025 · CA
Translational Research Program in Colorectal Cancer Disparities
$406,634Ulrike Peters · Fred Hutchinson Cancer Research Center · P20 · FY2021 · CA
IDO1 and Immunotolerance in Glioblastoma
$406,629Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2019 · NS
Immune cell control of ovarian cancer
$406,610Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Neuroimmunology of Malignant Brain Tumors: Innate Mechanisms
$406,525Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2016 · NS
Enhancing Solid Tumor lmmunotherapy with Targeted siRNA Delivery
$406,500David H Altreuter · Absco Therapeutics, Inc. D/B/A Abscotx · R43 · FY2025 · CA
Neural organoid models of the immunological microenvironment of glioblastoma for drug discovery applications
$406,500Connie S Lebakken · Stem Pharm, Inc. · R41 · FY2023 · CA